DOCSLIB.ORG

Lecture Notes- General Surgery

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lecture Notes- General Surgery Lecture Notes: General Surgery Companion website The book is supported by a website containing a free bank of interactive questions and answers. These can be found at: www.testgeneralsurgery.com The website includes: • Interactive Multiple-Choice Questions for each chapter • Interactive Short Answer Questions for each chapter Lecture Notes: General Surgery Harold Ellis CBE DM MCh FRCS Emeritus Professor of Surgery, Guy’s Hospital, London Sir Roy Calne MS FRCS FRS Emeritus Professor of Surgery, Addenbrooke’s Hospital, Cambridge Christopher Watson MD BChir FRCS Reader in Surgery and Honorary Consultant, Addenbrooke’s Hospital, Cambridge Twelfth Edition A John Wiley & Sons, Ltd., Publication This edition fi rst published 2011© 1965, 1968, 1970, 1972, 1977, 1983, 1987, 1993, 1998, 2002, 2006, 2011 © 2011 Harold Ellis, Sir Roy Y. Calne, Christopher J. E. Watson Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientifi c, Technical and Medical business to form Wiley-Blackwell. Registered offi ce: John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial offi ces: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offi ces, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identifi ed as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. First published 1965 Fifth edition 1977 Ninth edition 1998 Revised edition 1966 Sixth edition 1983 Reprinted 1999, 2000 Second edition 1968 Reprinted 1984, 1985, 1986 Tenth edition 2002 Third edition 1970 Seventh edition 1987 Reprinted 2003, 2004, 2005 Fourth edition 1972 Reprinted 1989 (twice) Eleventh edition 2006 Reprinted 1974 Eighth edition 1993 Twelfth Edition 2010 Revised reprint 1976 Reprinted 1994, 1996 Greek edition 1968 Portuguese edition 1979 Indonesian edition 1990 Turkish edition 2005 Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought. Library of Congress Cataloging-in-Publication Data Ellis, Harold, 1926– Lecture notes. General surgery / Harold Ellis, Sir Roy Calne, Christopher Watson. – 12th ed. p. ; cm. General surgery Includes bibliographical references and index. ISBN 978-1-4443-3440-1 (pbk. : alk. paper) 1. Surgery. I. Calne, Roy Yorke. II. Watson, Christopher J. E. (Christopher John Edward) III. Title. IV. Title: General surgery. [DNLM: 1. Surgical Procedures, Operative. WO 100] RD31.E4 2011 617–dc22 2010036446 A catalogue record for this book is available from the British Library. Set in 8.5/11pt Utopia by Toppan Best-set Premedia Limited 01 2011 Contents Introduction, vii 24 Acute appendicitis, 199 Acknowledgements, ix 25 The colon, 204 Abbreviations, xi 26 The rectum and anal canal, 218 27 Peritonitis, 230 1 Surgical strategy, 1 28 Paralytic ileus, 236 2 Fluid and electrolyte management, 5 29 Hernia, 239 3 Preoperative assessment, 10 30 The liver, 250 4 Postoperative complications, 15 31 The gallbladder and bile ducts, 266 5 Acute infections, 26 32 The pancreas, 276 6 Shock, 31 33 The spleen, 289 7 Tumours, 36 34 The lymph nodes and lymphatics, 292 8 Burns, 41 35 The breast, 295 9 The skin and its adnexae, 47 36 The neck, 308 10 The chest and lungs, 60 37 The thyroid, 311 11 The heart and thoracic aorta, 69 38 The parathyroids, 323 12 Arterial disease, 80 39 The thymus, 328 13 Venous disorders of the lower limb, 98 40 The suprarenal glands, 330 14 The brain and meninges, 105 41 The kidney and ureter, 335 15 Head injury, 114 42 The bladder, 353 16 The spine, 126 43 The prostate, 358 17 Peripheral nerve injuries, 137 44 The male urethra, 367 18 The oral cavity, 143 45 The penis, 370 19 The salivary glands, 153 46 The testis and scrotum, 374 20 The oesophagus, 158 47 Transplantation surgery, 384 21 The stomach and duodenum, 167 22 Mechanical intestinal obstruction, 183 Index, 391 23 The small intestine, 194 Companion website The book is supported by a website containing a free bank of interactive questions and answers. These can be found at: www.testgeneralsurgery.com The website includes: • Interactive Multiple-Choice Questions for each chapter • Interactive Short Answer Questions for each chapter Introduction The ideal medical student at the end of the clinical Because this book is written at student level, course will have written his or her own textbook principles of treatment only are presented, not – a digest of the lectures and tutorials assiduously details of surgical technique. attended and of the textbooks meticulously read. The need after only 4 years for a new, 12th, Unfortunately, few students are perfect, and most edition refl ects the rapid changes which are taking approach the qualifying examinations depressed place in surgical practice. We are confi dent that by the thought of the thousands of pages of excel- our constant updating will ensure that this volume lent and exhaustive textbooks wherein lies the will continue to serve the requirements of our wisdom required of them by the examiners. medical students. We advise you to read this book We believe that there is a serious need in these in conjunction with Clinical Cases Uncovered – days of widening knowledge and expanding syl- Surgery , which provides illustrated case studies, labus for a book that will set out briefl y the impor- MCQs, EMQs and SAQs, cases that correspond to tant facts in general surgery that are classifi ed, the chapters in this volume. analysed and as far as possible rationalized for the revision student. These lecture notes represent H . E . our own fi nal - year teaching; they are in no way a R.Y.C. substitute for the standard textbooks but are our C.J.E.W. attempts to draw together in some sort of logical way the fundamentals of general surgery. Acknowledgements We are grateful to our colleagues – registrars, (Chapters 21 and 30 ); and Andrew Doble (Chapters housemen and students – who have read and 41 – 46 ). criticized this text during its production, and Finally, we would like to acknowledge the con- to many readers and reviewers for their con- tinued help given by the staff at Wiley Blackwell, structive criticisms. In particular, we are indebted in particular to Jane Fallows, who has created to Simon Dwerryhouse (Chapters 20 and 21 ); some new diagrams and brought colour to others, Justin Davies (Chapters 22 , 23 and 25); Gordon Rebecca Huxley, who oversaw the production, and Wishart (Chapters 35 , 37 and 38 ); Neville Lindsey Williams, who has meticulously steered Jamieson (Chapters 30 – 33 and 40 ); Kathryn Nash this edition from text to fi nished product. Abbreviations ABPI ankle brachial pressure index HHT hereditary haemorrhagic telangiectasia ACE angiotensin - converting enzyme HHV human herpes virus ACTH adrenocorticotrophic hormone HIV human immunodefi ciency virus ADH antidiuretic hormone HLA human leucocyte antigen AFP α - fetoprotein HPOA hypertrophic pulmonary osteoarthropathy AIDS acquired immune defi ciency syndrome HPV human papilloma virus ALP alkaline phosphatase HRT hormone replacement therapy ALT alanine transaminase HTIG human tetanus immunoglobulin APACHE Acute Physiology And Chronic Health ICP intracranial pressure Evaluation ICSI intracytoplasmic sperm injection APUD amine precursor uptake and IFN - γ interferon γ decarboxylation IPMN intraductal papillary mucinous tumour ASA American Society of Anesthesiologists IVC inferior vena cava AST aspartate transaminase IVF in vitro fertilization ATN acute tubular necrosis IVU intravenous urogram BCG bacille Calmette – Gu é rin JVP jugular venous pressure CABG coronary artery bypass graft KSHV Kaposi sarcoma herpes virus CEA carcinoembryonic antigen ‘ KUB ’ kidneys, ureters and bladder CNS central nervous system LAD left anterior descending artery CRP C - reactive protein LCIS lobular carcinoma in situ CSF cerebrospinal fl uid LHRH luteinizing hormone- releasing hormone CT computed tomography MAG3 m ercapto - a cetyl tri g lycine DCIS ductal carcinoma in situ MCN mucinous cystic neoplasm DIC disseminated intravascular coagulopathy MEN multiple endocrine neoplasia DMSA dimercaptosuccinic acid MHC major histocompatibility complex DOPA dihydroxyphenyl alanine MIBG meta - iodobenzylguanidine
Load more

Recommended publications
  • What Does a Diagnosis of Myeloma Mean in 2015
    What does a diagnosis of Myeloma mean in 2015 Dr Aristeidis Chaidos Consultant Haematologist Hammersmith Hospital Learning objectives • define myeloma and related disorders • diagnosis & disease monitoring • “many myelomas”: staging & prognostic systems • the evolving landscape in myeloma treatment • principles of management with emphasis to care in the community • future challenges and novel therapies Myeloma – overview • malignancy of the plasma cells (PC): the terminally differentiated, antibody producing B cells • myeloma cells infiltrate the bone marrow • IgG or IgA paraprotein (PP) and/or free light chains in blood and urine • bone destruction • kidney damage • anaemia • despite great advances in the last 15 years myeloma remains an incurable disease Myeloma in figures • 1% of all cancers – 13% of blood cancers • median age at diagnosis: 67 years • only 1% of patients <40 years • 4 – 5 new cases per 100,000 population annually, but different among ethnic groups • 4,800 new myeloma patients in the UK each year • the prevalence of myeloma in the community increases with outcome improvements and aging population Myeloma related conditions smoldering symptomatic remitting plasma cell MGUS refractory myeloma myeloma relapsing leukaemia <10% PC ≥10% PC +/- ≥10% PC or plasmacytoma circulating PC PP <30g/L PP ≥30g/L Any PP in serum and/or urine extramedullary no organ no organ disease damage or damage or organ damage & symptoms symptoms symptoms Death MGUS monoclonal gammopathy of unknown significance • The most common pre-malignant condition:
    [Show full text]
  • Guidelines on the Assessment of Bleeding Risk Prior to Surgery Or Invasive Procedures
    guideline Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures British Committee for Standards in Haematology Y. L. Chee, 1 J. C. Crawford, 2 H. G. Watson1 and M. Greaves3 1Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, 2Department of Anaesthetics, Southern General Hospital, Glasgow, and 3Department of Medicine and Therapeutics, School of Medicine, University of Aberdeen, Aberdeen, UK surgery or invasive procedures to predict bleeding risk. The Summary aim is to evaluate the use of indiscriminate testing. Appro- Unselected coagulation testing is widely practiced in the priate testing of patients with relevant clinical features on process of assessing bleeding risk prior to surgery. This may history or examination is not the topic of this guideline. The delay surgery inappropriately and cause unnecessary concern target population includes clinicians responsible for assess- in patients who are found to have ‘abnormal’ tests. In addition ment of patients prior to surgery and other invasive it is associated with a significant cost. This systematic review procedures. was performed to determine whether patient bleeding history and unselected coagulation testing predict abnormal periop- Methods erative bleeding. A literature search of Medline between 1966 and 2005 was performed to identify appropriate studies. The writing group was made up of UK haematologists with Studies that contained enough data to allow the calculation of a special interest in bleeding disorders and an anaesthetist. the predictive value and likelihood ratios of tests for periop- First, the commonly employed coagulation screening tests erative bleeding were included. Nine observational studies were identified and their general and specific limitations (three prospective) were identified.
    [Show full text]
  • Surgery Guidelines Infection Prevention
    SURGERY GUIDELINES SURGICAL SITE INFECTION: REDUCING YOUR RISK A surgical site infection is a Stanford Hospital & Clinics is committed to implementing strategies to improve risk with any type of surgery. surgical care and to reduce the risk of You can take steps to reduce surgical site infections. your risk of surgical site We want your surgical experience at Stanford Hospital & Clinics to be positive. infection and complications. That experience includes educational • Talk with your healthcare provider materials that describe the process of your about your risk of infection and review surgery and the measures we take to ensure your safety. It is especially important to steps you can take to reduce your reduce the risk of infection. risk prior to the procedure. These are general guidelines. You will • Know the signs and symptoms be provided with more specific instructions of surgical site infection. related to your surgery before your discharge from the hospital. • Know how to reduce your risk while you are in the hospital. INFECTION PREVENTION stanfordhospital.org stanfordhospital.org PRIOR TO DAY OF AFTER SURGERY SURGERY SURGERY KEY POINTS HEALTHCARE TEAMS’ ROLE IN PREVENTION After your surgery and hospital stay, it is Tell your healthcare provider about other • Your surgeon may use electric clippers to important to watch for any changes in your medical problems you may have. Factors remove some of your hair before surgery. symptoms. Call your physician immediately or such as diabetes, obesity, smoking and some • Your surgical team will apply a skin antiseptic go to the nearest emergency room if you are medications could affect your surgery and immediately before the surgery experiencing any of the following symptoms: your treatment.
    [Show full text]
  • CV-Summer 2017.Pdf
    CURRICULUM VITAE NAME: MARY THERESE KILLACKEY, MD OFFICE ADDRESS: 1430 Tulane Avenue New Orleans, LA 70112 t 504.988.2317 f 504.988.1874 [email protected] PLACE OF BIRTH: Yonkers, NY EDUCATION: 1990-1994 Columbia College, Columbia University New York, NY, B.A. (Biology) 1994-1998 College of Physicians & Surgeons, Columbia University New York, NY M.D. POST-GRADUATE TRAINING: 6/1998-6/1999 Intern, General Surgery Strong Memorial Hospital University of Rochester Rochester, NY 6/1999-6/2003 Resident, General Surgery Strong Memorial Hospital University of Rochester Rochester, NY 7/2003-6/2005 Fellow, Abdominal Organ Transplant Surgery Recanati/Miller Transplant Institute The Mount Sinai Hospital New York, NY 11/2010 Leadership Development Program American Society of Transplant Surgeons Northwestern University Kellogg School of Management Chicago, IL 6/2015 Surgeons as Leaders Course American College of Surgeons Chicago, IL 9/2015-8/2016 Clinical Leadership Development Program Tulane School of Medicine, Office of the Dean New Orleans, LA 12/2015 Mid-Career Women Faculty Professional Development Seminar Association of American Medical Colleges Austin, TX 6/2016 Being a Resilient Leader Association of American Medical Colleges Washington, DC 6/2017 - 4/2018 Fellow, Executive Leadership in Academic Medicine Drexel University College of Medicine Philadelphia, PA ACADEMIC APPOINTMENTS: 7/2003-6/2005 Instructor in Surgery Mount Sinai School of Medicine New York, NY 10/2006-present Assistant Professor of Surgery and Pediatrics Tulane University
    [Show full text]
  • Medications to Avoid Before Surgery
    ENTRUST MEDICAL GROUP Pre‐operative Information Medications to Avoid Before Surgery It is important to avoid certain medications prior to surgery. The following medications can have effects on bleeding, swelling, increase the risk of blood clots, and cause other problems if taken around the time of surgery. Please notify your surgeon’s office if you are taking any vitamins, herbal medications/supplements as these can also cause problems during your surgery and should not be taken for the two week period before surgery and one week after surgery. It is extremely important that if you come down with a cold, fever, rash, or “any new” medical problem close to your surgery date, you should notify your surgeon’s office immediately. Section One: The following drugs contain aspirin and/or aspirin like effects that may affect your surgery (abnormal bleeding and bruising). These drugs should be avoided for at least two weeks prior to surgery. A.P.C. Doloprin Nuprin A.S.A. Easprin Orudis A.S.A. Enseals Ecotrin Pabalate‐SF Advil Emprin with Codeine Pamelor Aleve Endep Parnate Alka‐Seltzer Plus Equagesic Tablets Percodan Alka‐Seltzer Etrafon Pepto‐Bismol (all types) Anacin Excedrin Persantine Anaprox Feldene Phenteramine Ansaid Fiorinal Phenylbutzone Argesic Flagly Ponstel Arthritis pain formula Four Way Cold Tablets Propoxyphene Compound Arthritis strength Bufferin Gemnisyn Robaxisal Arthropan Liquid Gleprin Rufen AS.A. Goody’s S‐A‐C Ascriptin Ibuprofen (all types) Saleto Asperbuf Indocin Salocol Aspergum Indomethacin Sine‐Aid/Sine‐Off/Sinutab Aspirin (all brands) Lanorinal SK‐65 Compound Atromid Lioresal St. Joseph’s Cold Tab B.C.
    [Show full text]
  • Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series
    Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series National Council on Disability September 25, 2019 National Council on Disability (NCD) 1331 F Street NW, Suite 850 Washington, DC 20004 Organ Transplant Discrimination Against People with Disabilities: Part of the Bioethics and Disability Series National Council on Disability, September 25, 2019 This report is also available in alternative formats. Please visit the National Council on Disability (NCD) website (www.ncd.gov) or contact NCD to request an alternative format using the following information: [email protected] Email 202-272-2004 Voice 202-272-2022 Fax The views contained in this report do not necessarily represent those of the Administration, as this and all NCD documents are not subject to the A-19 Executive Branch review process. National Council on Disability An independent federal agency making recommendations to the President and Congress to enhance the quality of life for all Americans with disabilities and their families. Letter of Transmittal September 25, 2019 The President The White House Washington, DC 20500 Dear Mr. President, On behalf of the National Council on Disability (NCD), I am pleased to submit Organ Transplants and Discrimination Against People with Disabilities, part of a five-report series on the intersection of disability and bioethics. This report, and the others in the series, focuses on how the historical and continued devaluation of the lives of people with disabilities by the medical community, legislators, researchers, and even health economists, perpetuates unequal access to medical care, including life- saving care. Organ transplants save lives. But for far too long, people with disabilities have been denied organ transplants as a result of unfounded assumptions about their quality of life and misconceptions about their ability to comply with post-operative care.
    [Show full text]
  • General Surgery
    - 1 - KALEIDA HEALTH Name: ___________________________________ Date: ____________________________ DELINEATION OF PRIVILEGES - GENERAL SURGERY PLEASE NOTE: Please check the box for each privilege requested. Do not use an arrow or line to make selections. We will return applications that ignore this directive. GENERAL STATEMENTS - Privileges in Adult Surgery are separated into the following divisions: General Surgery and Plastic Surgery. Applicants desiring procedure privileges in more than one division must complete separate forms for each. Procedures designated with an asterisk (*) indicate that Moderate or Deep Sedation may be required. If you do not have Moderate or Deep Sedation privileges, you must invite a Kaleida Health anesthesiologist to participate in the procedure. Procedures are also separated into levels of complexity (Level I-A, Level I-B, Level I, Level II, and Level III), which require increasing levels of education and experience. In general, procedures learned during residency are grouped in Level I-A or Level I and are granted upon evidence of successful completion of residency training. Level II procedures may or may not require evidence of additional training beyond residency. Documentation of additional training and/or experience is required for all Level III procedures. LEVEL I-A PRIVILEGES Procedures which involve primarily wound care, can be done under local anesthetic and occasionally involve application of temporary skin coverage or application of agents to expedite wound healing. Can be performed by any competent
    [Show full text]
  • General Surgery Career Resource
    The American Journal of Surgery (2013) 206, 719-723 Association of Women Surgeons: Career Development Resources General surgery career resource Ana M. Parsee, M.D.a, Sharona B. Ross, M.D.b, Nancy L. Gantt, M.D.c, Kandace Kichler, M.D.d, Celeste Hollands, M.D.e,* aJohns Hopkins Hospital, Baltimore, MD, USA; bFlorida Hospital, Tampa, FL, USA; cNortheast Ohio Medical University, St. Elizabeth Health Center, Rootstown, OH, USA; dUniversity of Miami, Palm Beach Regional Campus, Palm Beach, FL, USA; eSt John’s Children’s Hospital, Springfield, IL, USA KEYWORDS: Abstract General surgery residency training can lead to a rewarding career in general surgery and General surgery; serve as the foundation for careers in several surgical subspecialties. It offers broad-based training with General surgery exposure to the cognitive and technical aspects of several surgical specialties and prepares graduating residency; residents for a wide range of career paths. This career development resource discusses the training as- Surgical fellowship; pects of general surgery. Surgical subspecialties; Ó 2013 Elsevier Inc. All rights reserved. Transition to practice; Surgery interest groups General surgery training provides the foundation for who enter medical school with an interest in surgery and many different surgical career paths. The training begins those who become interested early can become involved with a general surgery residency, which is usually followed in their schools’ surgery interest group (SIGs) as early as by either entry into practice or additional training. General the first day of medical school at most institutions. Each surgery residency programs provide broad-based training local SIG has different offerings to help students explore with exposure to the cognitive and technical aspects of and develop their interest in surgery as a career.
    [Show full text]
  • Posterior Cervical Discectomy: an Optimally Invasive Approach to Laterally Prolapsed Cervical Disc
    Original Research Article DOI: 10.18231/2455-8451.2016.0005 Posterior cervical discectomy: An optimally invasive approach to laterally prolapsed cervical disc Shashank Sah1,*, Suresh Kumar Kaushik2, Neeraj Prajapati3 1Associate Professor, Dept. of General Surgery, 2Associate Professor, Dept. of Orthopaedics, 3Associate Professor, Dept. of Radiology, SRMSIMS, Bareilly, Uttar Pradesh *Corresponding Author: Email: [email protected] Abstract Aim: Posterior cervical discectomy is one of the surgical techniques for management of laterally prolapsed cervical disc causing cervical radiculopathy. This method has remained under-utilized in comparison to the classic technique of Anterior Cervical Discectomy and Fusion (ACDF). The study was conducted to evaluate it’s feasibility in terms of ease, challenges and short term outcome. Material and Methods: This is a prospective study conducted over a period of 65 months. Patients visiting to neurosurgery/ orthopedics OPD’s with cervical disc diseases and requiring surgery, were further evaluated on the basis of selection criteria for the feasibility of posterior cervical discectomy. Patients meeting the selection criteria were then operated upon by this approach and the outcome was evaluated. Results: Posterior cervical discectomy is essentially a disc conserving, optimally invasive microscopic technique - best suited for selected subset of patients with laterally prolapsed disc causing radiculopathy. 21 out of 23 patients appreciated the surgical benefit by as early as 48 hours of operation. There were no complications. Conclusion: Posterior cervical discectomy is an excellent direct approach to the diseased segment provided case selection criteria are properly followed. Keywords: Cervical disc, Posterior cervical discectomy, Lamino-foraminotomy, Motion preserving cervical disc surgery Introduction approach has largely remained underutilized and Cervical disc disease is a prevalent and disabling therefore in the present study we evaluated this disorder.
    [Show full text]
  • Chiari Malformation by Ryan W Y Lee MD (Dr
    Chiari malformation By Ryan W Y Lee MD (Dr. Lee of Shriners Hospitals for Children in Honolulu and the John A Burns School of Medicine at the University of Hawaii has no relevant financial relationships to disclose.) Originally released August 8, 1994; last updated March 9, 2017; expires March 9, 2020 Introduction This article includes discussion of Chiari malformation, Arnold-Chiari deformity, and Arnold-Chiari malformation. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations. Overview Chiari malformation describes a group of structural defects of the cerebellum, characterized by brain tissue protruding into the spinal canal. Chiari malformations are often associated with myelomeningocele, hydrocephalus, syringomyelia, and tethered cord syndrome. Although studies of etiology are few, an increasing number of specific genetic syndromes are found to be associated with Chiari malformations. Management primarily targets supportive care and neurosurgical intervention when necessary. Renewed effort to address current deficits in Chiari research involves work groups targeted at pathophysiology, symptoms and diagnosis, engineering and imaging analysis, treatment, pediatric issues, and related conditions. In this article, the author discusses the many aspects of diagnosis and management of Chiari malformation. Key points • Chiari malformation describes a group of structural defects of the cerebellum, characterized by brain tissue protruding into the spinal canal. • Chiari malformations are often associated
    [Show full text]
  • Chiari Type II Malformation: Past, Present, and Future
    Neurosurg Focus 16 (2):Article 5, 2004, Click here to return to Table of Contents Chiari Type II malformation: past, present, and future KEVIN L. STEVENSON, M.D. Children’s Healthcare of Atlanta, Atlanta, Georgia Object. The Chiari Type II malformation (CM II) is a unique hindbrain herniation found only in patients with myelomeningocele and is the leading cause of death in these individuals younger than 2 years of age. Several theories exist as to its embryological evolution and recently new theories are emerging as to its treatment and possible preven- tion. A thorough understanding of the embryology, anatomy, symptomatology, and surgical treatment is necessary to care optimally for children with myelomeningocele and prevent significant morbidity and mortality. Methods. A review of the literature was used to summarize the clinically pertinent features of the CM II, with par- ticular attention to pitfalls in diagnosis and surgical treatment. Conclusions. Any child with CM II can present as a neurosurgical emergency. Expeditious and knowledgeable eval- uation and prompt surgical decompression of the hindbrain can prevent serious morbidity and mortality in the patient with myelomeningocele, especially those younger than 2 years old. Symptomatic CM II in the older child often pre- sents with more subtle findings but rarely in acute crisis. Understanding of CM II continues to change as innovative techniques are applied to this challenging patient population. KEY WORDS • Chiari Type II malformation • myelomeningocele • pediatric The CM II is uniquely associated with myelomeningo- four distinct forms of the malformation, including the cele and is found only in this population. Originally de- Type II malformation that he found exclusively in patients scribed by Hans Chiari in 1891, symptomatic CM II ac- with myelomeningocele.
    [Show full text]
  • 2005 Iowa Orthopedic Journal
    Designed for Wear Reduction • Improved Function • Optimal Kinematics4 VOLUME 25 2005 THERE IS A DIFFERENCE The Iowa Orthopaedic Journal DEPUY ROTATING PLATFORM KNEE 1 REDUCED WEAR BY 94% Polyethylene wear has been associated with osteolysis in the knee.2,3 * The rotating platform knee, used with GVF JOURNAL ORTHOPAEDIC THE IOWA polyethylene, reduced wear by 94% when compared to a fixed bearing knee. Results based on knee simulation testing. Available only from DePuy Orthopaedics. Trusted Innovation. 1 ASTM Symposium on Cross-linked Thermally Treated Ultra High Molecular Weight Polyethylene for Joint Replacements (data on file). Miami Beach, Florida Nov. 5 and 6, 2002. 2 Lewis, Peter; Cecil H. Rorabeck, Robert B. Bourne and Peter Devane. “Posteromedial Tibial Polyethylene Failure in Total Knee Replacements.” CORR Feb. 1994: 11-17. 3 Cadambi, Ajai, Gerard A. Engh, Kimberly A. Dwyer and Tuyethoa N. Vinh. “Osteolysis of the Distal Femur After Total Knee Arthroplasty.” The Journal of Arthroplasty Dec. 1994: 579-594. * GVF - Gamma Vacuum Foil IMPORTANT • The presence of osteomyelitis, pyrogenic infection or other overt infection of the These include: This Essential Product Information sheet does not include all of the information nec- knee joint; essary for selection and use of a device. Please see full labeling for all necessary infor- • Patients with loss of musculature or neuromuscular compromise leading to loss of •Vascular deficiency at the bone site; mation. function in the involved limb or in whom the requirements for its use would affect •Inadequate bone stock to assure both a firm press fit and close apposition of the cut recommended rehabilitation procedures.
    [Show full text]